Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The price varies based on factors such as location, provider type, and insurance coverage
Claims about "high oral bioavailability" in humans are not evidence-based
DSIP was discovered decades ago and initially attracted substantial scientific interest, yet large contemporary clinical programs did not emerge
Evidence in humans is early, so peptide therapy should complement, not replace, established rheumatology care
TLI test: If exocrine pancreatic insufficiency is suspected as the underlying cause, a trypsin-like immunoreactivity blood test confirms or rules this out
US$ 26.18
US$ 21.13
US$ 27.75
US$ 26.42
US$ 20.63
